Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth

Journal of Surgical Research

Volumn 185, Issue 1, 2013, Pages 264-272

  Kuo, Li Jen ^a,b,c   Hung, Chin Sheng ^b,c   Chen, Wei Yu ^d   Chang, Yu Jia ^a,b,c   Wei, Po Li ^a,b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Colon cancer; Glucose regulated protein 78; Vascular endothelial growth factor

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DISTANT METASTASIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANGIOGENESIS; COLON CANCER; GLUCOSE-REGULATED PROTEIN 78; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ADENOCARCINOMA; ANIMALS; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEAT-SHOCK PROTEINS; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84886729941     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.05.020     Document Type: Article

References (41)

1. M.M. Center, A. Jemal, R.A. Smith, and E. Ward Worldwide variations in colorectal cancer CA Cancer J Clin 59 2009 366
2. M.M. Center, A. Jemal, and E. Ward International trends in colorectal cancer incidence rates Cancer Epidemiol Biomark Prev 18 2009 1688
3. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277
4. Bureau of Health Promotion, Department of Health, Executive Yuan, Republic of China (Taiwan) Cancer Registry Annual Report, Republic of China (Taiwan), 2007 2010 Bureau of Health Promotion, Department of health, Executive Yuan, Republic of China (Taiwan) Taipei
5. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43
6. K. Plate From angiogenesis to lymphangiogenesis Nat Med 7 2001 150
7. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 85 1971 1182
8. J. Folkman How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture Cancer Res 46 1986 467
9. J. Folkman What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1990 4
10. G. Lurje, W. Zhang, and A.M. Schultheis Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer Ann Oncol 19 2008 1734
11. Y. Zhou, N. Li, W. Zhuang, and X. Wu Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population Mol Carcinog 50 2011 184
12. L.R. Kidd, G.N. Brock, and T.T. VanCleave Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival Cancer Causes Control 21 2010 1545
13. Z. Xiang, Z. Zeng, and Z. Tang Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome Cancer J 15 2009 519
14. A.L. Mulkeen, T. Silva, and P.S. Yoo Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells Arch Surg 141 2006 367
15. S.J. Kim, J.H. Seo, and Y.J. Lee Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells Oncology 68 2005 204
16. P.F. Engstrom Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy Pharmacotherapy 28 2008 18s
17. A. Tsuji Colorectal cancer chemotherapy and anti-EGFR therapy Gan To Kagaku Ryoho 38 2011 901
18. E. Aranda, A. Abad, and A. Carrato Treatment recommendations for metastatic colorectal cancer Clin Transl Oncol 13 2011 162
19. J. Fuloria Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer Onco Targets Ther 5 2012 133
20. Y. Kozutsumi, M. Segal, K. Normington, M.J. Gething, and J. Sambrook The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins Nature 332 1988 462
21. C. Jamora, G. Dennert, and A.S. Lee Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME Proc Natl Acad Sci U S A 93 1996 7690
22. Q. Wang, Z. He, and J. Zhang Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance Cancer Detect Prev 29 2005 544
23. J. Zhang, Y. Jiang, and Z. Jia Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer Clin Exp Metastasis 23 2006 401
24. U.K. Misra, R. Deedwania, and S.V. Pizzo Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78 J Biol Chem 281 2006 13694
25. M.S. Song, Y.K. Park, J.H. Lee, and K. Park Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade Cancer Res 61 2001 8322
26. H.R. Park, I.J. Ryoo, and S.J. Choo Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator Toxicology 229 2007 253
27. Y. Fu, J. Li, and A.S. Lee GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis Cancer Res 67 2007 3734
28. Y.J. Chang, C.J. Tai, and L.J. Kuo Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma Ann Surg Oncol 18 2011 2395
29. X. Xing, M. Lai, Y. Wang, E. Xu, and Q. Huang Overexpression of glucose-regulated protein 78 in colon cancer Clin Chim Acta 364 2006 308
30. H. Takahashi, J.P. Wang, H.C. Zheng, S. Masuda, and Y. Takano Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis Histol Histopathol 26 2011 663
31. Y.J. Chang, Y.P. Huang, Z.L. Li, and C.H. Chen GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells PLoS One 7 4 2012 e35123 10.1371/journal.pone.0035123
32. H.K. Lee, C. Xiang, and S. Cazacu GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis Neuro Oncol 10 2008 236
33. Y.J. Chang, C.C. Chiu, and C.H. Wu Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma Ann Surg Oncol 17 2010 1703
34. B. Hardy, A. Battler, C. Weiss, O. Kudasi, and A. Raiter Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells Biochem Pharmacol 75 2008 891
35. C.C. Chiu, C.Y. Lin, and L.Y. Lee Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention Mol Cancer Ther 7 2008 277
36. M.A. Arap, J. Lahdenranta, and P.J. Mintz Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands Cancer Cell 6 2004 275
37. E. Fasano, S. Serini, and E. Piccioni DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines Biochim Biophys Acta 1822 2012 1762
38. B. Hardy, A. Raiter, M. Yakimov, A. Vilkin, and Y. Niv Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity Cell Oncol (Dordr) 35 2012 345
39. N. Ferrara Vascular endothelial growth factor as a target for anticancer therapy Oncologist 9 Suppl 1 2004 2
40. Y. Baba, K. Nosho, and K. Shima HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers Am J Pathol 176 2010 2292
41. Y. Wu, M. Jin, and H. Xu Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer Clin Dev Immunol 2010 2010 pii: 537531